MEIS2 is an oncogenic partner in AML1-ETO-positive AML

Vegi, Naidu M.; Klappacher, Josef; Oswald, Franz; Mulaw, Medhanie A.; Mandoli, Amit; Thiel, Verena N.; Bamezai, Shiva; Feder, Kristin; Martens, Joost H. A.; Rawat, Vijay P. S.; Mandal, Tamoghna; Quintanilla-Martinez, Leticia; Spiekermann, Karsten; Hiddemann, Wolfgang; Doehner, Konstanze; Doehner, Hartmut; Stunnenberg, Hendrik G.; Feuring-Buske, Michaela; Buske, Christian

Publication services
→
Universitätsbibliographie
→
4 Medizinische Fakultät
→
View Item

« back

MEIS2 is an oncogenic partner in AML1-ETO-positive AML

Author:

Vegi, Naidu M.; Klappacher, Josef; Oswald, Franz; Mulaw, Medhanie A.; Mandoli, Amit; Thiel, Verena N.; Bamezai, Shiva; Feder, Kristin; Martens, Joost H. A.; Rawat, Vijay P. S.; Mandal, Tamoghna; Quintanilla-Martinez, Leticia; Spiekermann, Karsten; Hiddemann, Wolfgang; Doehner, Konstanze; Doehner, Hartmut; Stunnenberg, Hendrik G.; Feuring-Buske, Michaela; Buske, Christian

Tübinger Autor(en):

Quintanilla-Martinez, Leticia

Published in:

Cell Reports (2016), Bd. 16, H. 2, S. 498-507

Verlagsangabe:

Cell Press

Language:

English

Full text:

http://dx.doi.org/10.1016/j.celrep.2016.05.094

ISSN:

2211-1247